Drug intelligence / Profile preview

Visonac

Development stage
Unknown
Lead developer
Photocure
Modality
Hydrogel Systems → Drug Delivery Systems, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

Visonac is a novel photodynamic therapy (PDT) developed for the treatment of moderate to severe inflammatory acne. The therapy involves topical application of the Visonac cream to affected skin areas, followed by controlled illumination with a red light source. This process activates the photosensitizer in the cream, leading to production of reactive oxygen species that kill bacteria and have beneficial effects on sebaceous glands and inflammatory cells. Clinical studies have shown that Visonac PDT results in significant reduction in inflammatory lesions and overall improvement in acne severity, with good tolerability and no serious adverse events reported. The developer Photocure has obtained patents protecting its use for acne until 2025[2][5].

Brand names
Visonac
Other names
Visonac PDTVisonac cream

Beyond the preview

Go deeper on Visonac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Visonac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call